McKesson Co. (NYSE:MCK) Shares Purchased by Two Sigma Investments LP

Two Sigma Investments LP boosted its position in shares of McKesson Co. (NYSE:MCK - Free Report) by 548.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 164,741 shares of the company's stock after buying an additional 139,328 shares during the quarter. Two Sigma Investments LP owned 0.13% of McKesson worth $93,888,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Cibc World Market Inc. grew its position in McKesson by 6.3% in the 4th quarter. Cibc World Market Inc. now owns 20,252 shares of the company's stock valued at $11,542,000 after acquiring an additional 1,207 shares during the last quarter. Brentview Investment Management LLC bought a new position in McKesson in the 4th quarter valued at $3,018,000. Ingalls & Snyder LLC grew its position in McKesson by 8.2% in the 4th quarter. Ingalls & Snyder LLC now owns 13,824 shares of the company's stock valued at $7,878,000 after acquiring an additional 1,047 shares during the last quarter. Chicago Partners Investment Group LLC grew its position in McKesson by 85.0% in the 4th quarter. Chicago Partners Investment Group LLC now owns 1,262 shares of the company's stock valued at $745,000 after acquiring an additional 580 shares during the last quarter. Finally, Blue Trust Inc. grew its position in McKesson by 6.4% in the 4th quarter. Blue Trust Inc. now owns 7,830 shares of the company's stock valued at $4,462,000 after acquiring an additional 468 shares during the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently issued reports on MCK. Wells Fargo & Company increased their price objective on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a research note on Friday, March 14th. UBS Group upped their target price on McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Bank of America raised their price target on McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Evercore ISI increased their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a report on Thursday, February 6th. Finally, Mizuho raised their target price on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Three equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $686.69.

McKesson Trading Down 1.2%

Shares of NYSE:MCK traded down $8.43 on Thursday, hitting $710.30. 599,391 shares of the company were exchanged, compared to its average volume of 916,584. The stock's 50 day moving average price is $687.71 and its 200 day moving average price is $631.12. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $731.70. The firm has a market capitalization of $88.87 billion, a P/E ratio of 32.52, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53.

McKesson (NYSE:MCK - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $10.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.83 by $0.29. The firm had revenue of $90.82 billion for the quarter, compared to the consensus estimate of $94 billion. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The firm's revenue was up 18.9% on a year-over-year basis. During the same period in the prior year, the firm earned $6.18 EPS. On average, equities analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Monday, June 2nd will be issued a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Monday, June 2nd. McKesson's dividend payout ratio is presently 10.99%.

Insider Activity

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now owns 60,664 shares in the company, valued at approximately $36,276,465.36. This represents a 12.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the transaction, the chief accounting officer now owns 1,972 shares in the company, valued at $1,432,677.72. This represents a 21.59% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.11% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.